A Prospective Trial to Study the Evolution of Clonal Architecture of Tumors From Patients Treated With Molecular Targeted Agents
NACompletedINTERVENTIONAL
Enrollment
1,500
Participants
Timeline
Start Date
December 18, 2014
Primary Completion Date
March 31, 2025
Study Completion Date
March 31, 2025
Conditions
Metastatic Oncogen-driven Cancer
Interventions
PROCEDURE
Biopsy
Trial Locations (1)
94805
Gustave Roussy Cancer Campus Grand Paris, Villejuif
All Listed Sponsors
lead
Gustave Roussy, Cancer Campus, Grand Paris
OTHER
NCT02517892 - A Prospective Trial to Study the Evolution of Clonal Architecture of Tumors From Patients Treated With Molecular Targeted Agents | Biotech Hunter | Biotech Hunter